PRESS RELEASE published on 10/02/2025 at 09:05, 5 months 20 days ago BioNxt Reports Update on Targeted Chemotherapy Drug Delivery Platform BioNxt Solutions Inc. reports significant advancement in targeted chemotherapy delivery platform and upcoming definitive agreement. Proprietary technology aims at 10-fold increase in therapeutic effect while safeguarding healthy cells BioNxt Solutions Inc. Oncology Treatments Chemotherapy Delivery Platform Targeted Drug Delivery System Therapeutic Effect
BRIEF published on 09/29/2025 at 09:10, 5 months 23 days ago BioNxt Advances Cladribine Sublingual Drug Development for Multiple Sclerosis Drug Development Multiple Sclerosis Cladribine Bioavailability Sublingual
BRIEF published on 09/29/2025 at 09:10, 5 months 23 days ago BioNxt fait progresser le développement d'un médicament sublingual à base de cladribine pour le traitement de la sclérose en plaques Sclérose En Plaques Cladribine Développement De Médicaments Biodisponibilité Sublingual
PRESS RELEASE published on 09/29/2025 at 09:05, 5 months 23 days ago BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization BioNxt Solutions provides update on Cladribine sublingual thin-film drug reformulation program, targeting treatment of multiple sclerosis with improved bioavailability and patient adherence Multiple Sclerosis Cladribine Neurological Disorders BioNxt Solutions Drug Delivery Technologies
BRIEF published on 09/20/2025 at 03:50, 6 months 2 days ago BioNxt Solutions lève des actions pour régler sa dette Actions Ordinaires Règlement De La Dette Solutions BioNxt Valeurs Mobilières Canadiennes Accord De Dette
BRIEF published on 09/20/2025 at 03:50, 6 months 2 days ago BioNxt Solutions Completes Shares for Debt Settlement Common Shares Debt Settlement Debt Agreement Canadian Securities BioNxt Solutions
PRESS RELEASE published on 09/20/2025 at 03:45, 6 months 2 days ago BioNxt Solutions Announces Closing of Shares for Debt Settlement BioNxt Solutions Inc. announces successful debt settlement with creditor, issuing common shares and making cash payment. Company focuses on bioscience innovation and drug delivery technologies Common Shares Debt Settlement BioNxt Solutions Inc. Drug Delivery Technologies Bioscience Innovation
BRIEF published on 09/20/2025 at 01:35, 6 months 2 days ago BioNxt Solutions Inc. Engages Capital Markets Advisor and Investor Relations Professionals Stock Options Investor Relations Capital Markets BioNxt Solutions Terry Lynch
BRIEF published on 09/20/2025 at 01:35, 6 months 2 days ago BioNxt Solutions Inc. fait appel à des conseillers en marchés financiers et à des professionnels des relations avec les investisseurs. Relations Avec Les Investisseurs Marchés Des Capitaux Options Sur Actions Solutions BioNxt Terry Lynch
PRESS RELEASE published on 09/20/2025 at 01:30, 6 months 2 days ago Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms BioNxt Solutions Inc. Terry Lynch Investor Relations Professionals Bioscience Innovations Drug Delivery Platforms
Published on 03/20/2026 at 13:30, 2 days 8 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 9 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 9 hours 14 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 22 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 2 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 2 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 3 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 3 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA